Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium

被引:310
|
作者
Goldgur, Y [1 ]
Dyda, F [1 ]
Hickman, AB [1 ]
Jenkins, TM [1 ]
Craigie, R [1 ]
Davies, DR [1 ]
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1073/pnas.95.16.9150
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 integrase is an essential enzyme in the life cycle of the virus, responsible for catalyzing the insertion of the viral genome into the host cell chromosome; it provides an attractive target for antiviral drug design. The previously reported crystal structure of the HIV-1 integrase core domain revealed that this domain belongs to the superfamily of polynucleotidyltransferases. However, the position of the conserved catalytic carboxylic acids differed from those observed in other enzymes of the class, and attempts to crystallize in the presence of the cofactor, Mg2+, were unsuccessful. We report here three additional crystal structures of the core domain of HIV-1 integrase mutants, crystallized in the presence and absence of cacodylate, as well as complexed with Mg2+. These three crystal forms, containing between them seven independent core domain structures, demonstrate the unambiguous extension of the previously disordered helix alpha 4 toward the amino terminus from residue M154 and show that the catalytic E152 points in the general direction of the two catalytic aspartates, D64 and D116, In the vicinity of the active site, the structure of the protein in the absence of cacodylate exhibits significant deviations from the previously reported structures. These differences can be attributed to the modification of C65 and C130 by cacodylate, which was an essential component of the original crystallization mixture. We also demonstrate that in the absence of cacodylate this protein will bind to Mg2+, and could provide a satisfactory platform for binding of inhibitors.
引用
收藏
页码:9150 / 9154
页数:5
相关论文
共 50 条
  • [31] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [32] Tautomerism and Magnesium Chelation of HIV-1 Integrase Inhibitors: A Theoretical Study
    Liao, Chenzhong
    Nicklaus, Marc C.
    CHEMMEDCHEM, 2010, 5 (07) : 1053 - 1066
  • [33] An Inhibitory monoclonal antibody that binds to C-terminal domain of HIV-1 integrase blocks DNA binding to the protein
    Yi, J
    Skalka, AM
    FASEB JOURNAL, 2000, 14 (08): : A1325 - A1325
  • [34] THE DNA PROCESSING ACTIVITY OF HIV-1 INTEGRASE WITH MAGNESIUM AS METAL COFACTOR
    FOLTIN, SK
    HOLLER, TP
    HUPE, DJ
    FASEB JOURNAL, 1995, 9 (06): : A1398 - A1398
  • [35] HIV-1 integrase: A target for new AIDS chemotherapeutics
    Anthony, NJ
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 979 - 990
  • [36] A new DNA quadruplex that inhibits HIV-1 integrase
    不详
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2005, 22 (06): : 763 - 763
  • [37] Methylenebysphosphonates as new class of HIV-1 integrase inhibitors
    Anisenko, A.
    Agapkina, J.
    Korolev, S.
    Yanvarev, D.
    Kochetkov, S.
    Gottikh, M.
    FEBS JOURNAL, 2013, 280 : 365 - 366
  • [38] Synthesis of new potential HIV-1 integrase inhibitors
    Ferro, S
    Rao, A
    Zappalà, M
    Chimirri, A
    Barreca, ML
    Witvrouw, M
    Debyser, Z
    Monforte, P
    HETEROCYCLES, 2004, 63 (12) : 2727 - 2734
  • [39] Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors
    Meadows, D. Christopher
    Tantillo, Dean J.
    Gervay-Hague, Jacquelyn
    CHEMMEDCHEM, 2006, 1 (09) : 959 - +
  • [40] HIV-1 integrase inhibitor interactions at the active site: Prediction of binding modes unaffected by crystal packing
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (25) : 6136 - 6137